|
Originally published In Press as doi:10.1074/jbc.M106621200 on September 14, 2001
J. Biol. Chem., Vol. 276, Issue 45, 42043-42049, November 9, 2001
Defective Gi Protein Coupling in Two Formyl Peptide
Receptor Mutants Associated with Localized Juvenile Periodontitis*
Roland
Seifert and
Katharina
Wenzel-Seifert
From the Department of Pharmacology and Toxicology, University of
Kansas, Lawrence, Kansas 66045-2505
The formyl peptide receptor (FPR) is a
prototypical chemoattractant receptor expressed in neutrophils.
It is well known that the FPR couples to Gi proteins
to activate phospholipase C, chemotaxis, and cytotoxic cell functions,
but the in vivo role of the FPR in man has remained
elusive. Recently, F110S and C126W mutations of the FPR have been
associated with localized juvenile periodontitis. We studied FPR-F110S
and FPR-C126W in comparison with wild-type FPR (FPR-WT) by
coexpressing epitope-tagged versions of these receptors with the G
protein G i2 1 2 in
Sf9 insect cells. FPRs were efficiently expressed in Sf9
membranes as assessed by immunoblotting using the
2-adrenoreceptor as a standard. FPR-C126W differed from
FPR-WT and FPR-F110S in migration on SDS-polyacrylamide gels and
tunicamycin-sensitive glycosylation. FPR-WT efficiently reconstituted high-affinity agonist binding and agonist- and inverse
agonist-regulated guanosine 5'-O-(3-thiotriphosphate)
(GTP S) binding to
G i2 1 2. In contrast,
FPR-F110S only weakly reconstituted agonist-stimulated GTP S binding,
and FPR-C126W was completely inefficient. Collectively, our data show
almost complete and complete loss of Gi protein coupling in
FPR-F110S and FPR-C126W, respectively. The severe functional defects in
FPR-F110S and FPR-C126W contrast with the discrete clinical symptoms
associated with these mutations, indicating that loss of FPR function
in host defense is, for the most part, readily compensated.
*
This work was supported by National Institutes of Health
Center of Biomedical Research Excellence Award 1-P20-RR15563 and matching support from the State of Kansas and the University of Kansas.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Pharmacology and Toxicology, University of Kansas, 5003 Malott Hall, Lawrence, KS 66045-2505. Tel. and Fax: 785-864-3536; E-mail:
kwenzel@falcon.cc.ukans.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev.,
June 1, 2009;
61(2):
119 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Babbin, W. Y. Lee, C. A. Parkos, L. M. Winfree, A. Akyildiz, M. Perretti, and A. Nusrat
Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors
J. Biol. Chem.,
July 14, 2006;
281(28):
19588 - 19599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. VanCompernolle, K. L. Clark, K. A. Rummel, and S. C. Todd
Expression and Function of Formyl Peptide Receptors on Human Fibroblast Cells
J. Immunol.,
August 15, 2003;
171(4):
2050 - 2056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fu, C. Dahlgren, and J. Bylund
Subinhibitory Concentrations of the Deformylase Inhibitor Actinonin Increase Bacterial Release of Neutrophil-Activating Peptides: a New Approach to Antimicrobial Chemotherapy
Antimicrob. Agents Chemother.,
August 1, 2003;
47(8):
2545 - 2550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Seifert, K. Wenzel-Seifert, T. Burckstummer, H. H. Pertz, W. Schunack, S. Dove, A. Buschauer, and S. Elz
Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor
J. Pharmacol. Exp. Ther.,
June 1, 2003;
305(3):
1104 - 1115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. HENDERSON, M. WILSON, L. SHARP, and J. M. WARD
Actinobacillus actinomycetemcomitans
J. Med. Microbiol.,
December 1, 2002;
51(12):
1013 - 1020.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|